In the clinical setting, resveratrol, which has been proposed to act as a potential PPAR antagonist [30], has been linked as a potential suppressor of endometriosis, an effect that is triggered through activation of the TRAIL (TNF-related apoptosis-inducing ligand) pathway [31]. This evidence concerns the gene PPARA and endometriosis.